There's a 'bearish-to-bullish' reversal happening in this mid-cap biotech stock, says Carter Worth
- Posted on February 27, 2026
- By CNBC
- 5 Views
There's a 'bearish-to-bullish' reversal happening in this mid-cap biotech stock, says Carter Worth
Carter Worth takes a look at the charts for mid-cap biotech Immunovant.
